MedPath

Comparing Perceptual Motor Training and Repetitive Facilitation Exercises on UE in Stroke

Not Applicable
Not yet recruiting
Conditions
Stroke
Registration Number
NCT06688812
Lead Sponsor
Riphah International University
Brief Summary

The aim of the study is to determine the comparative effects of perceptual motor training and repetitive facilitation exercises on upper limb quality of movement and motor function in Stroke patients.

Detailed Description

Perceptual-motor training enhances proprioception, spatial awareness, and coordination through object manipulation. On the other hand, Repetitive facilitation exercises aim to improve motor control and reduce spasticity by stimulating muscles repetitively. Decreased dexterity, coordination, muscle tone abnormalities, and diminished sensation are frequently observed in stroke patients. Effective rehabilitation in daily tasks depends on coordinated efforts among muscles, joints, and body segments, influenced by environmental factors and personal constraints. Visual input, perception, and cognitive processing play crucial roles in action planning during rehabilitation.

This is a randomized clinical trial. The data will be collected from DHQ hospital, Sargodha. 50 stroke patients will be included using convenience sampling. The participants who meet the inclusion criteria will be randomly allocated into two groups. Twenty-five participants will be included in both Groups A and B. Group A (perceptual motor training with routine physical therapy) and Group B (Repetitive facilitation exercises with routine physical therapy) will receive 60 minutes treatment session that consists of 40 minutes of intervention and 20 minutes of routine physical therapy four sessions per week for 8 weeks.

Quality of movement will be assessed using Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) and motor function by Fugl-Meyer Assessment (FMA-UE) Assessments will occur at baseline, 4 weeks, and 8 weeks. Data analysis will utilize SPSS version 27 for Windows, with statistical significance set at p ≤ 0.05.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • Participants who have a history of significant neurological or psychiatric disorders, other than stroke, that could interfere with upper limb motor recovery
  • Patients with pain, contracture and profound atrophy in arm and fingers.
  • Participants with severe cognitive dysfunction that would interfere with understanding instructions from the physician or therapist.
  • Presence of any other musculoskeletal condition. e.g. (Frozen shoulder, any recent fractures of upper limb.
  • Any accompanying diseases or disorders, other than stroke, that could interfere with upper extremity training.
  • Uncontrolled health conditions for which exercise was contraindicated.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
1. Motor Evaluation Scale For Upper Extremity In Stroke Patients (MESUPES)8 week

A 17-items into two sub scales ; MESUPES Arm function; 8 items(score 0-5) MESUPES-Hand function; 9 items (score0-2) objective evaluation scale designed to assess quality of movement of arm and hand function after stroke. MESUPES takes 5-15 min to complete. Total score 58. A higher score indicates the greater the quality of movement

2. Fugl-Meyer Assessment (FMA):8 weeks

The Fugl-Meyer Assessment is used to assess motor function. It is a well-designed, feasible and efficient clinical examination method that has been tested widely in the stroke population. A three-level ordinal scale (0, can perform no part of the test; 1, performs test partially; 2, performs test normally) is applied to each item. A total possible score for the upper extremity is 66. The higher the score, the better the performance.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr. Faisal Masood Teaching Hospital

🇵🇰

Sargodha, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath